1 study found for:    22643560 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Bevacizumab;   Drug: Erlotinib

Indicates status has not been verified in more than two years